6:06 PM
 | 
Dec 20, 2012
 |  BC Extra  |  Top Story

Ultragenyx raises $75 million in series B

Rare disease company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) raised $75 million in a series B round led by new investor Adage Capital Partners. New investors...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >